Gene · 3881
KRT31: keratin 31
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. KRT31: keratin 31. Genes, record 3881. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3881
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q15323 | Keratin, type I cuticular Ha1 | 416 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents31
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2026213056 A1 | 2026-10-08 | 1 | Q15323 | Espacenet |
| WO 2026213063 A1 | 2026-10-08 | 1 | Q15323 | Espacenet |
| EP 4795068 A1 | 2026-08-26 | 3 | Q15323 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 50668 | Q15323 | Espacenet |
| EP 4508075 A1 | 2025-02-19 | 3 | Q15323 | Espacenet |
| EP 4508076 A1 | 2025-02-19 | 3 | Q15323 | Espacenet |
| KR 1020240124223 A | 2024-08-16 | 11 | Q15323 | Espacenet |
| KR 1020230173058 A | 2023-12-26 | 11 | Q15323 | Espacenet |
| KR 1020230120594 A | 2023-08-17 | 11 | Q15323 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 42986 | Q15323 | Espacenet |
1 to 10 of 31
See all 31 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants899
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | KRT31 papers | Newest fiscal year |
|---|---|---|---|
| ZIADK031117 | Development of Drugs Acting at Adenosine Receptors | 17 | 2025 |
| ZIADK031126 | Computer Modeling of G Protein-Coupled Receptors | 8 | 2025 |
| ZIADK031115 | Functionalized Congeners of Bioactive Compounds | 7 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| P01AI089618 | Structure-function analysis of infection- and vaccine-induced B-cell repertoires | 4 | 2025 |
| ZICAI005111 | Design of Antigenically-Specific Probes for Sera Analysis and MAb Isolation | 4 | 2025 |
| P30AI060354 | Harvard University Center for AIDS Research | 3 | 2025 |
| R35GM119774 | Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation | 3 | 2025 |
| T32AI007417 | The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program | 3 | 2025 |
| ZIAAI001211 | Immunobiology and Virology of Influenza A Virus | 3 | 2025 |
1 to 10 of 899Source NIH's project files
See all 899 nih grantsPapers1,648
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cytochrome P450-mediated metabolism of K31, a Ko143-derived ATP-binding cassette subfamily G member 2 inhibitor. | Drug Metab Dispos | 2026 | 42285009 | PubTator, text mining | PubMed |
| Evaluating 7‑Aminopyrazolo[4,3‑d]pyrimidines as Human A1 and A3 Adenosine Receptor Antagonists. | ACS Omega | 2026 | 42222808 | PubTator, text mining | PubMed |
| Injectable polysaccharide-based hydrogel delivering Poria cocos extracellular vesicles promotes hair regeneration in androgenetic alopecia via Wnt/β-catenin signaling. | Int J Biol Macromol | 2026 | 42142777 | PubTator, text mining | PubMed |
| SARS-CoV-2 and Influenza Co-Circulation and Co-Vaccination: A Narrative Review. | Vaccines (Basel) | 2026 | 41893818 | PubTator, text mining | PubMed |
| Small molecule-constrained paratope mimetic bicyclic peptides as potent inhibitors of group 1 and 2 influenza A virus hemagglutinins. | Proc Natl Acad Sci U S A | 2026 | 41875158 | PubTator, text mining | PubMed |
| Post elimination of lymphatic filariasis: a situation analysis of brugian filariasis and vector potentialities within the filarial transmission belt in Sri Lanka. | Parasit Vectors | 2026 | 41792828 | PubTator, text mining | PubMed |
| Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selection. | bioRxiv | 2026 | 41757067 | PubTator, text mining | PubMed |
| Synthesis and Antitumor Potency of 2E,21E-bis-(2-Pyridinylidene)-hollongdione in NCI-60 Panel and Zebrafish Model. | Int J Mol Sci | 2026 | 41751950 | PubTator, text mining | PubMed |
| High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains. | Elife | 2026 | 41725518 | PubTator, text mining | PubMed |
| CH•••S hydrogen bonds drive molecular recognition of ergothioneine by the microbial transporter. | Sci Adv | 2026 | 41719410 | PubTator, text mining | PubMed |
1 to 10 of 1,648
See all 1,648 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3881
GET https://conductscience.org/api/genes/v1/3881/patents?page=2